Saying that the revenue is up 400% is pointless when you consider that it has to go up a whooping 11250% to be cash flow positive.I will still hold for another quarter or 2 only beacause it is not worth selling at .001
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025